The benefits of Gynofort in the treatment of vulvovaginitis candidiasis

R. Vlădăreanu, C. Bosoancă

Rezumat: Vulvovaginal candidiasis is a condition characterized by signs and symptoms vulvovaginal inflammation caused by the presence of Candida spp. Single dose treatments that are based on the imidazole antifungal activity seems to be nearly ideal for the clinical management of vulvu-candidal vaginitis and is secured to maximum compliance with the administration to patients. Single-dose therapy minimize the disadvantages of long-term regimen. Guidelines recommend butoconazole nitrate as first-line therapy in the treatment of uncomplicated vulvovaginal candidiasis.
Cuvinte cheie: vulvovaginal, inflammation, imidazole, therapy.